Anna Klimovich | Biochemistry | Young Scientist Award

Dr. Anna Klimovich | Biochemistry | Young Scientist Award 

Dr. Anna Klimovich | G.B. Elyakov Pacific Institute of Bioorganic Chemistry Far-Eastern Branch of the Russian Academy of Sciences | Russia

Dr. Anna Klimovich is a PhD candidate in biochemistry with a decade of experience as a research fellow, specializing in the investigation of biologically active compounds derived from marine organisms of the Far Eastern and tropical seas using advanced experimental models of human pathologies in laboratory animals. She works as a research assistant in the Laboratory of Molecular Pharmacology and Biomedicine at the Pacific Institute of Bioorganic Chemistry, contributing extensively to fundamental and applied biomedicine. Her scientific portfolio includes 40 publications indexed in Web of Science and Scopus, supported by 199 citations across 162 documents and an h-index of 8, reflecting her strong research impact. She has completed seven research projects and is an inventor or co-inventor on seven patents focused on bioactive marine compounds and their therapeutic potential. Her research areas span biology, biochemistry, biomedicine, natural biologically active substances, and preclinical trials, with collaborative work involving Far Eastern Federal University in Vladivostok. Dr. Klimovich has contributed significantly to the characterization of marine peptides and metabolites, including the sea anemone peptide HCRG21, which exhibits analgesic, anti-inflammatory, and anxiolytic activities and demonstrates therapeutic potential for allergic dermatitis and psoriasis. She has also studied the peptide HCIQ2c1 with anti-inflammatory and neuroprotective properties, and the sea anemone peptides Hcr 1b-2, Hcr 1b-4, and AnmTX Sco 9a-1, which show strong anxiolytic, anti-inflammatory, and analgesic effects. Her work further includes discovering the antidiabetic and antiglycemic activities of the peptide Mgf, evaluating antimicrobial and antitumor effects of phenylphascaplysine alkaloid derivatives, and identifying the ability of triterpene glycosides from sea cucumbers—Cucumarioside A0-1, Djakonovioside A—and the peptide Hct-S3 to inhibit tumor metastasis. Additionally, she contributed to demonstrating that asterripeptides A–C from marine fungi possess therapeutic activity in treating infected wounds. Her research advances marine-derived therapeutic discoveries with high relevance to pharmacology, biotechnology, and translational biomedicine.

Profiles: Scopus | Orcid

Featured Publications

Klimovich, A., Kvetkina, A., Deryavko, Y., Priymenko, N., Popkova, D., Bystritskaya, E., Isaeva, M., Gladkikh, I., Sintsova, O., & Leychenko, E. (2025). TRPV1 blocker, peptide HCRG21 from sea anemone Heteractis magnifica, exhibits effectiveness in psoriasis and dermatitis in in vivo models. International Journal of Molecular Sciences, 26(21), 10644. https://doi.org/10.3390/ijms262110644

Klimovich, A. A., Chingizova, E. A., Pislyagin, E. A., Kotelnikov, V. N., & Shperling, I. A. (2025). Eksperimental’no-funktsional’naya otsenka ranozazhivlyayushchey aktivnosti gidrogelya na osnove karboksimetiltsellyulozy s biologicheski aktivnymi veshchestvami iz gidrobiontov Tikhogo okeana pri termicheskom ozhoge [Experimental and functional evaluation of the wound-healing activity of a carboxymethylcellulose-based hydrogel with bioactive substances from Pacific Ocean hydrobionts in a thermal burn model]. Clinical and Fundamental Medicine, 2, 5–12. https://doi.org/10.24866/3033-5485/2025-2/5-12

Zhidkov, M. E., Smirnova, P. A., Grammatikova, N. E., Isakova, E. B., Shchekotikhin, A. E., Styshova, O. N., Klimovich, A. A., & Popov, A. M. (2025). Comparative evaluation of the antibacterial and antitumor activities of marine alkaloid 3,10-dibromofascaplysin. Marine Drugs, 23(2), 68. https://doi.org/10.3390/md23020068

Klimovich, A. A., Kvetkina, A. N., Deryavko, Y. V., Priymenko, N. A., & Leychenko, E. V. (2024). Peptide TRPV1 channel blocker, HCRG21, effectively suppresses inflammation in a calcipotriol-induced allergic dermatitis model. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601127

Pavlenko, A. P., Klimovich, A. A., Yurchenko, E. A., Kvetkina, A. N., & Leychenko, E. V. (2024). Sea anemone Heteractis magnifica toxin Hct-S3 suppresses the migration of solid Ehrlich adenocarcinoma cells inoculated into BALB/C mice. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601206

Klimovich, A. A., Styshova, O. N., Popov, A. M., Moskvina, T. V., Tsybulsky, A. V., Derunov, D. A., & Stonik, V. A. (2020). Experimental study of therapeutic efficacy of the topical preparation “Kourochitin” in skin allergy. Letters in Drug Design & Discovery, 17(10), 1234–1241.

Prof. Sergey Kozlov | Neuroscience | Best Researcher Award

Prof. Sergey Kozlov | Neuroscience | Best Researcher Award

Shemiakin-Ovchinnikov Institute of bioorganic chemistry RAS, Russia.

Dr. Sergey Kozlov is a DSc and Head of the Laboratory of Neuroreceptors and Neuroregulators at the Shemiakin-Ovchinnikov Institute of Bioorganic Chemistry. He also teaches at the Federal State Russian Biotechnological University. His research focuses on the rational search for active molecules and the analysis of their structure-function relationships, particularly for potential healthcare applications. His most notable contributions include discovering ligands for acid-sensitive ion channels, which have promising therapeutic potential for treating pain, inflammation, drug addiction, anxiety, and neurodegenerative conditions such as stroke.

Profile

Scopus
Orcid

🎓 Education

Prof. Sergey Kozlov is a distinguished scientist and educator specializing in bioorganic chemistry and biotechnology. He earned his Doctor of Science (DSc) from the Shemiakin-Ovchinnikov Institute of Bioorganic Chemistry, where he conducted advanced research in biochemical processes and molecular interactions. Currently, he serves as a teaching faculty member at the Federal State Russian Biotechnological University, where he contributes to academic development and scientific research in biotechnology. With extensive expertise in biomolecular studies, Prof. Kozlov plays a crucial role in training future researchers and advancing innovation in bioorganic chemistry.

💼 Experience

Professor Sergey Kozlov is the Head of the Laboratory of Neuroreceptors and Neuroregulators at the Shemiakin-Ovchinnikov Institute of Bioorganic Chemistry. He is also a Professor & Researcher at the Federal State Russian Biotechnological University. Additionally, he collaborates with various Russian chemical laboratories on the functional testing of low molecular weight compounds.

His expertise likely involves bioorganic chemistry, neurobiology, and possibly pharmacology, with a focus on receptor interactions and the regulation of neurochemical processes in the brain.

🔬 Research Interests

Dr. Kozlov's research focuses on protein chemistry, including:

Separation of natural mixtures and structure determination

Activity analysis of compounds using imaging and electrophysiology

Development of animal models for testing new molecules

Production of recombinant proteins and receptor mutagenesis
His work has contributed significantly to understanding acid-sensitive ion channels, which play a role in pain management, inflammation, addiction, anxiety, and neurodegeneration.

🏆 Awards & Recognitions

Member – The International Society on Toxinology

Member – Federation of European Biochemical Societies (FEBS)

Hirsch Index: 28 (WoS)

Patents: 19 published, 2 under review

Consultancy/Industry Projects: 2 completed

Research Projects: 6 (4 completed, 2 ongoing)

📚 Selected Publications

Mutagenesis of the Peptide Inhibitor of ASIC3 Channel Introduces Binding to Thumb Domain of ASIC1a but Reduces Analgesic Activity
Marine Drugs, Aug 2024 | DOI: 10.3390/md22090382
🧬 Examines peptide inhibitors of ASIC3 channels and their effect on pain relief.

Opioid Analgesic as a Positive Allosteric Modulator of Acid-Sensing Ion Channels
Int. J. Mol. Sci., Jan 2024 | DOI: 10.3390/ijms25031413
💊 Investigates opioid analgesics as modulators of ASIC channels for potential pain management.

Venom-gland transcriptomics and proteomics of the Tibellus oblongus spider
Dataset, Oct 2023 | DOI: 10.6084/m9.figshare.21842034
🕷️ Provides genomic insights into spider venom composition.

Fifty Years of Animal Toxin Research at the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry RAS
Int. J. Mol. Sci., Sep 2023 | DOI: 10.3390/ijms241813884
🏛️ Reviews five decades of toxin research at IBCh RAS.

Dual Modulator of ASIC Channels and GABA<sub>A</sub> Receptors from Thyme Alters Fear-Related Hippocampal Activity
Int. J. Mol. Sci., Aug 2023 | DOI: 10.3390/ijms241713148
🌿 Explores a thyme-derived compound affecting ASIC and GABA receptors linked to anxiety.

 

 

 

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

University of Catania, Italy.

Prof. Dr. Antonio Rescifina, born on December 23, 1964, in Messina, Italy, is a distinguished researcher and professor in Organic Chemistry. He currently serves as a Full Professor in the Department of Pharmaceutical Sciences at the University of Catania, where he has been a member of the faculty since 1996. His research focuses on the synthesis of organic compounds with applications in pharmaceuticals, environmental chemistry, and materials science.

Profile

Scopus

Orcid

Education 🎓

Prof. Rescifina holds a degree in Chemistry and Pharmaceutical Technology from the University of Messina (1989), with honors. He later obtained another degree in Pharmacy (1991) and completed a Ph.D. in Chemical Sciences with a specialization in Organic Chemistry from the University of Catania (1995).

Experience 💼

Prof. Rescifina has had an extensive career in research and teaching. He worked as a researcher at the University of Catania and the University of Messina before becoming a professor. Over the years, he has contributed significantly to scientific advancements in organic chemistry, working on numerous projects funded by both national and international organizations. His roles have included being a scientific coordinator of various research projects.

Research Interests 🔬

Organic Chemistry and Pharmaceutical Applications
Dr. Yucra's work primarily focuses on the synthesis of novel chemical compounds for pharmaceutical and industrial applications. His research aims to create more efficient, cost-effective, and sustainable solutions to current challenges in these sectors.

Carbon Dioxide Decarbonization & Valorization
He is committed to developing innovative carbon dioxide decarbonization and valorization processes, which aim to transform CO₂ from a harmful greenhouse gas into valuable industrial products, contributing to environmental sustainability.

Green Chemistry
Dr. Yucra emphasizes green chemistry principles, working on solutions that minimize environmental impact, enhance energy efficiency, and reduce the use of toxic chemicals, all while maintaining effective chemical processes.

Pharmaceutical Nanostructures
In his work on pharmaceutical nanostructures, he explores the development of nanoscale materials that can be used for targeted drug delivery, improving the effectiveness of treatments while reducing side effects.

Supramolecular Catalysis
His interest in supramolecular catalysis focuses on creating catalysts that work through non-covalent interactions, leading to more efficient and selective chemical reactions, with potential applications in pharmaceuticals and green chemistry.

Sustainable Chemistry Materials
Finally, Dr. Yucra is involved in the design and development of innovative materials for sustainable chemistry, aiming to create alternatives to traditional chemical processes that are more sustainable, eco-friendly, and economically viable.

.

Awards 🏆

Prof. Rescifina's work has earned him national recognition, including the prestigious Abilitazione Scientifica Nazionale (National Scientific Qualification) for Full Professor in 2018.

His research contributions have been acknowledged in various funded projects and prestigious conferences.

Selected Publications 📚

Designing a Monolithic Photo-Fenton Catalyst Using a Fungal Hydroxypyrone Metabolic Derivative
Materials Today Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Valentina Giglio, Chiara Zagni, Sabrina Carola Carroccio, Vincenzo Paratore, Guglielmo Guido Condorelli, Giuseppe Floresta, Sandro Dattilo, Antonio Rescifina.

Efficient Green Solvent-Free CO2/Epoxide Cycloaddition Catalyzed by a β-Cyclodextrin-Imidazolium-Based Ionic Liquid
Journal of Industrial and Engineering Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Rita Turnaturi, Sandro Dattilo, Vincenzo Patamia, Giuseppe Floresta, Sabrina Carola Carroccio, Tommaso Mecca, Antonio Rescifina.

A Full Carbon-Based Thermoplastic Photocatalyst for Organic Pollutants Abatement: An Experimental and Computational Study
FlatChem
January 2025 | Journal article
Contributors: Lidia Mezzina, Angelo Nicosia, Vincenzo Patamia, Antonio Rescifina, Luisa D’Urso, Vincenzo Paratore, Placido Giuseppe Mineo.

Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
International Journal of Molecular Sciences
January 20, 2025 | Journal article
Contributors: Rocco Buccheri, Alessandro Coco, Lorella Pasquinucci, Emanuele Amata, Agostino Marrazzo, Antonio Rescifina.

Bio-Based Palladium Catalyst in Cryogel for Cross-Coupling Reactions
Materials Chemistry Frontiers
2024 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Vincenzo Paratore, Guglielmo Guido Condorelli, Sabrina Carola Carroccio, Antonio Rescifina.